ScholarIQanswers from OpenAlex

Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial

PaperCitations, authors & open-access status

Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial have?

ScholarIQcitation count

Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial has 79 citations in the OpenAlex counts ScholarIQ stores.

When was Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial published?

ScholarIQyear

Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial has 2003 year in the ScholarIQ index.

What is the open-access status of Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial?

ScholarIQoa status

Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial has closed oa status in the ScholarIQ index.

What is the DOI of Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial?

ScholarIQdoi

The DOI for Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial is on the source record.

What is the PMID of Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial?

ScholarIQpmid

The PMID for Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial is on the source record.

What is the OpenAlex record for Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial?

ScholarIQopenalex

The OpenAlex for Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial